scholarly journals A rare but serious complication of GreenLight HPS photoselective vaporization of the prostate: prostatic capsular perforation with bilateral thigh urinomas and osteitis pubis

2013 ◽  
Vol 7 (1-2) ◽  
pp. 105 ◽  
Author(s):  
David Harriman ◽  
Brian E. Mayson ◽  
Ercole F. Leone
Keyword(s):  
Laser System ◽  
Prostatic Hyperplasia ◽  
Potassium Titanyl Phosphate ◽  
Published Data ◽  
Medical Systems ◽  
Osteitis Pubis ◽  
Adjacent Structures ◽  
Photoselective Vaporization ◽  
Urinary Extravasation ◽  
Potassium Titanyl Phosphate Laser

The use of lasers to perform photoselective vaporization of the prostate (PVP) has been widely accepted as a safe and effective treatment for benign prostatic hyperplasia with very few reported complications. To date, most of the published data report outcomes for the 80-W potassium-titanyl-phosphate laser. A more potent laser, the 120-W GreenLight HPS, was introduced in 2006 and provides more efficient vaporization of prostatic tissue and decreased operating times. Despite these benefits, the increased energy applied to the prostate evokes concerns of potential serious complications, including capsular perforation and injury to adjacent structures. A more powerful laser system, the 180-W GreenLight XPS laser (American Medical Systems, Minnetonka, MN) has recently become available. We report a rare but serious complication of GreenLight HPS PVP resulting in prostatic capsular perforation with urinary extravasation, presenting with bilateral thigh urinomas and osteitis pubis.

scholarly journals A rare case of recurrent urinary obstruction and acute renal failure from cystitis cystica et glandularis

2012 ◽  
Vol 6 (2) ◽  
Author(s):  
Justin X.G. Zhu ◽  
Manal Y. Gabril ◽  
Alp Sener
Keyword(s):  
Laser System ◽  
Potassium Titanyl Phosphate ◽  
Published Data ◽  
Medical Systems ◽  
Osteitis Pubis ◽  
Adjacent Structures ◽  
Photoselective Vaporization ◽  
Urinary Extravasation ◽  
Cystitis Cystica ◽  
Potassium Titanyl Phosphate Laser

The use of lasers to perform photoselective vaporization of the prostate (PVP) has been widely accepted as a safe and effectivetreatment for benign prostatic hyperplasia with very few reported complications. To date, most of the published data report outcomesfor the 80-W potassium-titanyl-phosphate laser. A more potent laser, the 120-W GreenLight HPS, was introduced in 2006 and provides more efficient vaporization of prostatic tissue anddecreased operating times. Despite these benefits, the increased energy applied to the prostate evokes concerns of potential serious complications, including capsular perforation and injury to adjacent structures. A more powerful laser system, the 180-WGreenLight XPS laser (American Medical Systems, Minnetonka, MN) has recently become available. We report a rare but serious complication of GreenLight HPS PVP resulting in prostatic capsularperforation with urinary extravasation, presenting with bilateral thigh urinomas and osteitis pubis.

scholarly journals Safety and efficacy of photoselective vaporization of the prostate using the 180-W GreenLight XPS laser system in patients taking oral anticoagulants

2018 ◽  
Vol 46 (3) ◽  
pp. 1230-1237 ◽  
Author(s):  
Alper Eken ◽  
Bülent Soyupak
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
International Prostate Symptom Score ◽  
Oral Anticoagulants ◽  
Laser System ◽  
Urine Volume ◽  
Prostatic Hyperplasia ◽  
Urinary Flow ◽  
Residual Urine Volume ◽  
Photoselective Vaporization ◽  
Maximum Urinary Flow

Objective To evaluate the safety and efficacy of the 180-W GreenLight XPS laser system for the treatment of benign prostatic hyperplasia in patients taking oral anticoagulants. Methods All consecutive patients admitted for lower urinary tract symptoms associated with benign prostatic hyperplasia from November 2012 to October 2016 and who underwent photoselective vaporization of the prostate with the 180-W GreenLight XPS laser were included in the study. The perioperative outcomes examined were the operating time, laser time, energy usage, and duration of postoperative catheterization. Functional parameters (International Prostate Symptom Score, maximum urinary flow rate, and post-void residual urine volume), prostate volume, and serum prostate-specific antigen concentration were examined at baseline and 3 months. Perioperative complications, if any, were noted. Results All functional parameters (International Prostate Symptom Score, maximum urinary flow rate, and post-void residual urine volume) significantly improved from baseline to 3 months. A small number of patients experienced at least one minor adverse event. There was no difference in the rate of adverse events between patients who were and were not taking anticoagulants. Conclusions Photoselective vaporization with a 180-W laser is an efficacious and safe treatment for benign prostatic hyperplasia, even in patients taking anticoagulant medications.

Sign in / Sign up

Export Citation Format

Share Document